NIH Consulting Ban Will Have Minor Impact On Hiring, Retention, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A National Institutes of Health review has found only a small number of consulting relationships between researchers and pharmaceutical companies, NIH Deputy Director Kington says. The new policy must be approved by the White House.